Adamis Pharmaceuticals has announced an important addition to its intellectual property with receipt of a notice of allowance of patent claims supporting its cancer immunotherapy portfolio in the US. Notice of allowance is the final step ...
Tags: Cancer Immunology, Cancer, Cancer cure
Adamis Pharmaceuticals has signed an agreement to completely acquire 3M Company's MMM -0.36% Taper Dry Powder Inhaler (DPI) technology. Additionally, the company has entered into an agreement to exclusively license the platform technology ...
Tags: Adamis Pharmaceuticals, Dry Powder